Literature DB >> 20849516

Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy.

F Syed1, E Ahmadi, S A Iqbal, S Singh, D A McGrouther, A Bayat.   

Abstract

BACKGROUND: Overproduction of collagen and its abnormal assembly are hallmarks of keloid scars. Type I/III collagen ratios are altered in keloids compared with normal skin. Fibroblasts from different sites in keloid tissue, perilesional compared with intralesional and extralesional sites, show differential apoptosis and contraction. Additionally, early vs. later cell culture passages display differential collagen expression. We therefore hypothesize that keloid fibroblasts from the growing margin of the keloid express higher levels of collagen type I and III, and that collagen production is altered by extended cell culture passage.
OBJECTIVES: (i) To measure collagen I and III at mRNA and protein levels quantitatively in keloid fibroblasts, growth media and tissue sections; and (ii) to perform tissue staining for collagen I and III expression in different lesional sites.
METHODS: Keloid fibroblast cultures from intralesional, perilesional and extralesional sites (n = 8 separate keloid cases, yielding 64 biopsy samples) were established from passage 0 to passage 3. Collagen I and III mRNA was quantified using quantitative reverse transcription-polymerase chain reaction. We also measured the protein levels quantitatively by developing a highly specific and sensitive capture sandwich enzyme-linked immunosorbent assay. A novel in-cell Western blotting was carried out in addition to haematoxylin and eosin and Herovici staining on keloid tissue sections for collagen I and III.
RESULTS: Collagen types I and III were significantly higher (P < 0·03) in fibroblasts from the growing margin (perilesional site) compared with extralesional and intralesional keloid biopsy sites. As the passage number increased, the amount of collagen I significantly (P < 0·05) decreased and the collagen I/III ratio also decreased.
CONCLUSIONS: Our data show that cells from the growing margin of keloid scars have a higher production of collagen I and III compared with other lesional sites. Additionally, temporal extension of cell passage affects collagen production. Clinically these findings may influence selection and interpretation of extended cell passage and provide future direction for lesional site-specific therapy in keloid scars.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20849516     DOI: 10.1111/j.1365-2133.2010.10048.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  41 in total

1.  Cellular senescence as a possible mechanism for halting progression of keloid lesions.

Authors:  Shohreh Varmeh; Ainara Egia; Duncan McGrouther; Steven R Tahan; Ardeshir Bayat; Pier Paolo Pandolfi
Journal:  Genes Cancer       Date:  2011-11

Review 2.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.

Authors:  Meilang Xue; Christopher J Jackson
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

3.  Effect of collagen nanotopography on keloid fibroblast proliferation and matrix synthesis: implications for dermal wound healing.

Authors:  Lalitha Muthusubramaniam; Tatiana Zaitseva; Michael Paukshto; George Martin; Tejal Desai
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

4.  Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans.

Authors:  Judilyn Fuentes-Duculan; Kathleen M Bonifacio; Mayte Suárez-Fariñas; Norma Kunjravia; Sandra Garcet; Tristan Cruz; Claire Q F Wang; Hui Xu; Patricia Gilleadeau; Mary Sullivan-Whalen; Michael H Tirgan; James G Krueger
Journal:  Exp Dermatol       Date:  2017-02-28       Impact factor: 3.960

5.  Expressions of Collagen I and III in Hypoxic Keloid Tissue.

Authors:  Endah Wulandari; Sri Widia A Jusman; Yefta Moenadjat; Ahmad A Jusuf; Mohamad Sadikin
Journal:  Kobe J Med Sci       Date:  2016-07-25

6.  MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.

Authors:  Shengzhi Mu; Bei Kang; Weihui Zeng; Yaowen Sun; Fan Yang
Journal:  Mol Cell Biochem       Date:  2016-04-13       Impact factor: 3.396

7.  Degenerate wave and capacitive coupling increase human MSC invasion and proliferation while reducing cytotoxicity in an in vitro wound healing model.

Authors:  Michelle Griffin; Syed Amir Iqbal; Anil Sebastian; James Colthurst; Ardeshir Bayat
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

9.  CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

Authors:  Mehrnaz Gharaee-Kermani; Sathish Kasina; Bethany B Moore; Dafydd Thomas; Rohit Mehra; Jill A Macoska
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

10.  Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity.

Authors:  Farhatullah Syed; Hitesh J Sanganee; Subir Singh; Ashwani Bahl; Ardeshir Bayat
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.